Low risk of cervical cancer during a long period after negative screening in the Netherlands

British Journal of Cancer

Volumn 88, Issue 7, 2003, Pages 1054-1057

  Van Den Akker Van Marle, M E ^a   Van Ballegooijen, M ^a   Habbema, J D F ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cervical cancer; Negative screening; Relative risk

Indexed keywords

ADULT; ARTICLE; CANCER RESEARCH; CANCER RISK; CANCER SCREENING; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; NETHERLANDS; PAPANICOLAOU TEST; PERIODICITY; PRIORITY JOURNAL; RISK FACTOR; UTERINE CERVIX CANCER;

ADULT; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; NETHERLANDS; RISK; UTERINE CERVICAL NEOPLASMS;

EID: 0038707358     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600843     Document Type: Article

References (21)

1. Anonymous (1998) The screening muddle. Lancet 351: 459
2. Beral V, Hermon C, Munoz N, Devesa SS (1994) Trends in cancer incidence and mortality. Cancer Surv 19/20: 265-285
3. Berget A (1979) Influence of population screening on morbidity and mortality of cancer of the uterine cervix in Maribo Amt. Dan Med Bull 26: 91-100
4. Central Cancer Registry (1993) Overview of incidence of carcinoma of the cervix uteri in Friesland, Rotterdam, and The Hague in the years 1960-1970. Koningin Wilhelmina Fonds.
5. Clarke EA, Anderson TW (1979) Does screening by 'Pap' smears help prevent cervical cancer? A case-control study. Lancet 2: 1-4
6. Cuzick J, Boyle P (1988) Trends in cervix cancer mortality. Cancer Surv 7: 417-439
7. Eddy DM (1987) The frequency of cervical cancer screening. Comparison of a mathematical model with empirical data. Cancer 60: 1117-1122
8. Gustafsson L, Adami HO (1990) Cytologic screening for cancer of the uterine cervix in Sweden evaluated by identification and simulation. Br J Cancer 61: 903-908
9. Gyrd-Hansen D, Holund B, Andersen P (1995) A cost-effectiveness analysis of cervical cancer screening: health policy implications. Health Policy 34: 35-51
10. IARC Working Group on Evaluation of Cervical Cancer Screening Programmes (1986a) Screening for Cancer of the Uterine Cervix. Lyon: Scientific Publications series
11. IARC Working Group on Evaluation of Cervical Cancer Screening Programmes (1986b) Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. Br Med J 293: 659-64
12. Laara E, Day NE, Hakama M (1987) Trends in mortality from cervical cancer in the nordic countries: association with organised screening programmes. Lancet 1: 1247-1249
13. Magnus K, Langmark F, Andersen A (1987) Mass screening for cervical cancer in Ostfold county of Norway 1959-77. Int J Cancer 39: 311-316
14. Mitchell HS, Giles GG (1996) Cancer diagnosis after a report of negative cervical cytology. Med J Aust 164: 270-273
15. Raffle AE, Alden B, Mackenzie EF (1995) Detection rates for abnormal cervical smears: what are we screening for? Lancet 345: 1469-1473
16. Sasieni PD, Cuzick J, Lynch-Farmery E (1996) Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group. Br J Cancer 73: 1001-1005
17. van Ballegooijen M (1998) Effects and costs of cervical cancer screening Thesis. Department of PuNic Health, Erasmus University, Rotterdam.
18. van der Graaf Y, Zielhuis GA, Peer PG, Vooijs PG (1988) The effectiveness of cervical screening: a population-based case-control study. J Clin Epidemiol 41: 21-26
19. van Oortmarssen GJ, Habbema JD (1991) Epidemiological evidence for age-dependent regression of pre-invasive cervical cancer. Br J Cancer 64: 559-565
20. van Oortmarssen GJ, Habbema JD (1995) Duration of preclinical cervical cancer and reduction in incidence of invasive cancer following negative pap smears. Int J Epidemiol 24: 300-307
21. Viikki M, Pukkala E, Hakama M (1999) Risk of cervical cancer after a negative Pap smear. J Med Screen 6: 103-107